Ingemar Persson

The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months

Björn Wettermark, Niklas Hammar, C. MichaelFored et al. · Pharmacoepidemiology and Drug Safety · 2006 · 1.9K citations · Full text

Pharmacy, Pharmacology, Clinical Pharmacology +15

The Risk of Breast Cancer after Estrogen and Estrogen–Progestin Replacement

Leif Bergkvist, Hans‐Olov Adami, Ingemar Persson et al. · New England Journal of Medicine · 1989 · 619 citations

Medicine, Endocrinology, Oncology +13

The Relation between Survival and Age at Diagnosis in Breast Cancer

Hans‐Olov Adami, Birgitta Malker, Lars Holmberg et al. · New England Journal of Medicine · 1986 · 551 citations

Medicine, Oncology, Aging +14

Cancer risk after a hospital discharge diagnosis of endometriosis

Louise A. Brinton, Gloria Gridley, Ingemar Persson et al. · American Journal of Obstetrics and Gynecology · 1997 · 548 citations

Medicine, Gynecology, Oncology +10

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

Cecilia Magnusson, John A. Baron, N. Correia et al. · International Journal of Cancer · 1999 · 418 citations

Medicine, Endocrinology, Oncology +17